PBM
Psyence Biomedical Ltd.
NASDAQ · Healthcare · Biotechnology · CA
$4.12
−2.37%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-58.5%
Return on equity
-54.1%
Return on assets
-52.6%
Return on invested capital
0.00x
Asset turnover
-$8.1M
Cash from operations
$1.89
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026